Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04095273
Brief Title: Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug

First Submitted : September 18, 2019
First Submitted that Met QC Criteria : September 18, 2019
First Posted : September 19, 2019

Last Update Submitted that Met QC Criteria : April 24, 2022
Last Update Posted : April 26, 2022